Trexo Robotics has reached an incredible milestone, helping children take more than 100 million steps with its groundbreaking robotic brace. The device, designed to support children with disabilities, enables them to gain strength, endurance, and proper gait patterns. It has been a transformative tool for kids with a variety of conditions, including cerebral palsy, spinal muscular atrophy, muscular dystrophy, stroke, brain injury, hemi- and paraplegia, spinal cord injuries, Rett syndrome, and other neuromuscular disorders.

Founded in 2016 by CEO Manmeet Maggu and CTO Rahul Udasi in Ontario, Canada, Trexo Robotics was born out of a personal mission to help Maggu’s nephew. The company’s innovative brace customizes each child’s gait and adjusts over time to match the child’s progress. The device can modify gait patterns, step speed, weight-bearing capacity, and level of support, adapting to the evolving needs of each user. Additionally, Trexo’s brace offers two operational modes: endurance and strength training, ensuring that the child’s specific therapeutic needs are met.

In a significant leap forward for nuclear safety, General Atomics Electromagnetic Systems (GA-EMS) has announced the successful completion of a 120-day irradiation testing period for its innovative SiGA nuclear fuel cladding. This milestone, achieved at the Advanced Test Reactor (ATR) at Idaho National Laboratory, was designed to assess the performance of SiGA cladding under extreme radiation conditions.

The rigorous testing exposed unfueled SiGA-clad rods to the intense radiation environment of a pressurized water reactor, simulating the harsh conditions they would face in a real-world nuclear power plant. According to GA-EMS, the SiGA cladding withstood the irradiation with no significant mass change, indicating excellent performance and resistance to radiation damage.

Scientists have made a groundbreaking advancement in atomic-level control of matter, a leap that could transform both fundamental scientific understanding and practical applications, particularly in the realm of pharmaceuticals. This achievement, led by physicists at the University of Bath in collaboration with an international team, could revolutionize the way researchers develop medications, improving both precision and efficiency in chemical processes.

While controlling single-molecule reactions with specific outcomes has become standard in laboratories worldwide, this level of mastery was not always achievable. Over a decade ago, IBM researchers demonstrated the potential of atomic manipulation by creating A Boy and His Atom, the world’s smallest movie, by moving individual molecules—each comprising two bonded atoms—frame by frame. Although this was a landmark achievement, controlling chemical reactions with multiple outcomes remained elusive. This limitation has been a challenge, especially in drug synthesis, where controlling byproducts could improve efficiency.

Idemitsu Kosan, a leading Japanese company, has launched what it claims to be the world’s first racing engine oil made from plant-based raw materials for more than 80% of its base oil. This revolutionary product combines top-tier racing performance with API SP certification, a significant milestone in the automotive industry. According to a recent market survey conducted by Trending Future Research Institute Inc., this oil is the first of its kind for four-wheeled vehicles to combine American Petroleum Institute (API) certification, plant-based oil, and exceptional racing performance.

The survey, conducted between December 2023 and February 2024, highlighted the breakthrough in engine oil technology, confirming that Idemitsu IFG Plantech Racing oil is the only product on the market to offer both environmental benefits and high-level performance in racing conditions.

Chinese researchers have developed the BHMbot-B, a highly agile 15 mm-long microrobot capable of quick forward and backward movements, making it ideal for navigating tight and confined spaces. This innovative design combines a variety of advanced technologies to offer unprecedented mobility and adaptability, enabling it to perform tasks in environments where larger machines would struggle.

The BHMbot-B achieves its remarkable versatility through a unique control mechanism. The robot’s forward and backward motion is made possible by aligning the vibratory movements of its magnet, cantilever, and linkages using a process known as vibration mode transition control. This allows the robot to switch between motion modes with precision, enabling it to maneuver through challenging environments efficiently.

Thanks to revolutionary advancements in CRISPR technology, medical specialists are on the brink of transforming the treatment and prevention of genetic disorders and diseases. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a Nobel Prize-winning gene-editing tool that allows scientists to cut and modify DNA with unprecedented precision. By using the Cas9 enzyme, CRISPR can activate or deactivate genes and even insert new DNA to correct genetic abnormalities, revolutionizing our ability to address previously untreatable conditions.

Now, researchers from the USC Alfred E. Mann Department of Biomedical Engineering have taken CRISPR to the next level by incorporating focused ultrasound. This new tool enables precise targeting of CRISPR’s gene-editing abilities to specific areas of the body, significantly improving its efficiency and accuracy. The team is currently exploring how this technology can enhance cancer immunotherapy.